IVBT (Innovation1 Biotech) Short-Term Debt: $0.05 Mil (As of Feb. 2024)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

IVBT Innovation1 Biotech Inc IVBT
12 GF Score
Price $0.00
View Full Analysis

What is Innovation1 Biotech Short-Term Debt?

Innovation1 Biotech IVBT 12 Short-Term Debt is $0.05 Mil as of Feb. 2024. GuruFocus rates IVBT with a GF Score™ of 12/100.

Innovation1 Biotech's Short-Term Debt for the quarter that ended in Feb. 2024 was $0.05 Mil.

Innovation1 Biotech's quarterly Short-Term Debt increased from Aug. 2023 ($0.01 Mil) to Nov. 2023 ($0.05 Mil) but then stayed the same from Nov. 2023 ($0.05 Mil) to Feb. 2024 ($0.05 Mil).

Innovation1 Biotech's annual Short-Term Debt declined from Aug. 2021 ($0.16 Mil) to Aug. 2022 ($0.01 Mil) but then stayed the same from Aug. 2022 ($0.01 Mil) to Aug. 2023 ($0.01 Mil).

Innovation1 Biotech Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Innovation1 Biotech Short-Term Debt Related Terms

Innovation1 Biotech Short-Term Debt Historical Data

* Premium members only.

The historical data trend for Innovation1 Biotech's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Innovation1 Biotech Short-Term Debt Chart

Innovation1 Biotech Annual Data
Trend Aug15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22 Aug23
Short-Term Debt
Get a 7-Day Free Trial Premium Member Only 0.08 0.84 0.16 0.01 0.01

Innovation1 Biotech Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.01 0.01 0.01 0.05 0.05
IVBT
12GF Score
Innovation1 Biotech Inc IVBT
Short-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Short-Term Debt →
What does a Short-Term Debt of $0.05 Mil mean?
Innovation1 Biotech (IVBT) has a Short-Term Debt of $0.05 Mil as of Feb. 2024.
Is Innovation1 Biotech's Short-Term Debt too high?
Innovation1 Biotech's current Short-Term Debt is $0.05 Mil. Overall, Innovation1 Biotech has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Innovation1 Biotech's Short-Term Debt compare to NVIV and PXMD?
Innovation1 Biotech's Short-Term Debt of $0.05 Mil can be compared against companies in the Diversified Financial Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Short-Term Debt for a Diversified Financial Services company?
A good Short-Term Debt depends on the Diversified Financial Services industry context. However, Short-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Short-Term Debt mean?
A high Short-Term Debt can signal that a stock is expensive relative to its fundamentals. Innovation1 Biotech's current Short-Term Debt is $0.05 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Innovation1 Biotech stock overvalued right now?
Innovation1 Biotech (IVBT) has a current Short-Term Debt of $0.05 Mil. The current Short-Term Debt is $0.05 Mil. Innovation1 Biotech's overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Short-Term Debt calculated?
Short-Term Debt is calculated from a company's financial statements. For Innovation1 Biotech (IVBT), the current Short-Term Debt is $0.05 Mil as of Feb. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Innovation1 Biotech Business Description

Address 7 Grand View Avenue, Somerville, MA, USA, 02143
Innovation1 Biotech Inc is a shell company.
12GF Score

Get the complete analysis for IVBT

Short-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price